Crinetics Pharmaceuticals Overview
Crinetics Pharmaceuticals Target Price
Analysts' 12-month price predictions for CRNX.
Share Price
$33.01
Average Target Price
$75.50
128.7% upside
128.7% upside2 analysts in the last 4 months
High: $91 | Low: $60
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-03-24 | Stifel NicolausAlex Thompson | $60 | 81.8% upside |  |
| 2025-02-28 | JMP Securities | $91 | 175.7% upside | |
| 2024-08-09 | H.C. WainwrightDouglas Tsao | $69 | 109% upside | |
| 2024-06-04 | OppenheimerLeland Gershell | $74 | 124.2% upside | |
| 2024-05-23 | Robert W. BairdBrian Skorney | $62 | 87.8% upside | |
| 2024-05-22 | Morgan StanleyJeffrey Hung | $70 | 112.1% upside | |
| 2024-05-07 | Piper SandlerYasmeen Rahimi | $97 | 193.9% upside | |
| 2024-03-20 | JMP SecuritiesJonathan Wolleben | $80 | 142.4% upside | |
| 2024-03-13 | OppenheimerLeland Gershell | $54 | 63.6% upside | |
| 2023-08-31 | OppenheimerLeland Gershell | $40 | 21.2% upside | |
| 2022-05-26 | Leerink Partners | $39 | 18.1% upside | |